Real-world Outcomes of Nicotine Replacement Therapy in Acute Coronary Syndrome
Abstract Body (Do not enter title and authors here): Introduction: Acute Coronary Syndrome (ACS) is a major global health issue, with smoking as a significant modifiable risk factor. Smoking cessation reduces recurrent coronary events, making it crucial in ACS management. Current protocols recommend smoking cessation education during hospitalization and referral to smoking cessation or outpatient cardiac rehabilitation programs, where nicotine replacement therapy (NRT) and bupropion are available. NRT, including patches, gum, and lozenges, helps alleviate withdrawal symptoms by providing a controlled nicotine dose.
Hypothesis: We hypothesize that cautious initiation of NRT during hospitalization benefits ACS patients, with the benefits outweighing the risks. This study seeks to provide clarity and contribute to evidence-based guidelines for ACS management.
Methods: In this retrospective cohort study, data were gathered from the TriNetX database. The study compared two cohorts: 122,198 patients who received NRT and were hospitalized for acute myocardial infarction (AMI) or unstable angina (UA), and 160,387 patients who did not receive NRT but were admitted for the same conditions. The follow-up period began on the day of the index event and continued for 30 days. Cardiovascular outcomes were compared between propensity score-matched patients with and without NRT.
Results: Patients receiving NRT had a reduced risk of several cardiovascular outcomes compared to those who did not receive NRT, including atrial fibrillation and flutter (RR [95% CI]=0.822[0.792-0.854, p<0.01]) and ventricular fibrillation and flutter (RR [95% CI]=0.715[0.654-0.781, p<0.01]). The risk of death was also reduced (RR [95% CI]=0.701[0.678-0.726, p<0.01]). Hospital readmissions were less frequent in the NRT group (RR [95% CI]= 0.960[0.955-0.965, p<0.01]). Additionally, the risk of cardiac arrest was lower (RR [95% CI]= 0.698[0.660-0.738, p<0.01]), and supraventricular tachycardia (SVT) was less common (RR [95% CI]= 0.883[0.827-0.942, p<0.01]). These results highlight the potential benefits of NRT in reducing the risk of various cardiac events following AMI or UA.
Conclusions: The cautious initiation of NRT during hospitalization can benefit ACS patients where the benefits outweigh the risks. This study aims to provide clarity and contribute to evidence-based guidelines for ACS management.
Dhaliwal, Jasninder
( University of California, Riverside
, Redlands
, California
, United States
)
Sekhon, Manraj
( University of California, Riverside
, Redlands
, California
, United States
)
Rajotia, Arush
( University of California, Riverside
, Redlands
, California
, United States
)
Singh, Swaiman
( Mayo Clinic
, Rochester
, Minnesota
, United States
)
Author Disclosures:
Jasninder Dhaliwal:DO NOT have relevant financial relationships
| Manraj Sekhon:DO NOT have relevant financial relationships
| Arush Rajotia:DO NOT have relevant financial relationships
| Kamleshun Ramphul:DO NOT have relevant financial relationships
| Swaiman Singh:No Answer